The table below shows ALX ONCOLOGY HOLDINGS INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
-
$0.00
$0.00
$1.18M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$77.00M
$116.37M
$141.79M
$98.40M
$60.17M
$28.96M
SG&A
$23.85M
ALXO annual revenue (10-K history)
ALX ONCOLOGY HOLDINGS INC reported annual revenue of $0.00 for fiscal year 2022. Over the 5 fiscal years shown, annual revenue declined from $2.07M (FY 2018) to $0.00. Figures come from the company's audited annual reports as filed with the SEC.